Hua Shi

Hua Shi


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
YXYuangao Xu
Yuangao Xu
HSHua Shi
Hua Shi
JXJieyu Xiong
Jieyu Xiong
YWYikun Wu
Yikun Wu
XWXiaoyu Wu
Xiaoyu Wu
SXShuxiong Xu
Shuxiong Xu
Objective This study aimed to identify potential susceptibility loci for testicular germ cell tumors (TGCT) through a comprehensive multi-omics analysis. Methods A Mendelian randomization (MR) analysis was conducted to investigate the causal relationships between immune cell phenotypes and TGCT. Summary-based Mendelian Randomization (SMR) and colocalization analyses were subsequently performed to examine candidate phenotypes and TGCT using quantitative trait locis from multiple datasets. Differential gene expression analysis was employed to explore the immune landscape of the target gene in the TGCT tumor microenvironment using UCSC databases. Additionally, potential pathway mechanisms were investigated to elucidate the functional role of candidate genes. Results MR analysis identified a significant causal association between the immune cell phenotype HLA-DR on monocytes and TGCT (p = 0.02). SMR analysis revealed that BDH2 was significantly associated with TGCT susceptibility (OR = 0.597, p = 2.21e-07). Colocalization analysis suggested shared genetic variation between BDH2 and TGCT (PP.H4 = 0.95). Immunohistochemistry staining confirmed that BDH2 mRNA levels were significantly lower in TGCT tissues than in normal controls (p < 0.001). In the TGCT tumor microenvironment, lower BDH2 expression was associated with higher immune scores, with T cells and B cells predominantly enriched in the low-expression group, whereas monocytes and endothelial cells were more abundant in the high-expression group. Furthermore, members of the HLA family, exhibited significant correlations between their methylation levels and low BDH2 expression groups. Pathway analysis indicated that BDH2 may influence TGCT progression through the RAS-MAPK signaling pathway. Conclusions Our findings support a significant susceptibility relationship between the phenotype HLA-DR on monocytes, BDH2, and TGCT.


27 May 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
GHGuangYi Hong
GuangYi Hong
YWYiKun Wu
YiKun Wu
SHShiYu Huang
ShiYu Huang
YHYang Hu
Yang Hu
YZYing Zhang
Ying Zhang
SXShuxiong Xu
Shuxiong Xu
Clear cell renal cell carcinoma (ccRCC) is one of the most aggressive urological malignancies and a highly immunogenic cancer. Yet, its pathogenesis is still not fully understood. This study analyzed the role of the miR-320 family in ccRCC using bioinformatics algorithms and a series of in vitro experiments. miR-4429 was found to be significantly down-regulated in ccRCC tissues and cell lines, while overexpression of miR-4429 significantly inhibited renal cancer cell proliferation, migration, and invasion in vitro. In addition, the UALCAN database, immunohistochemistry, and protein blotting results showed that CD274 expression was up-regulated in ccRCC tissues and correlated with higher histologic grading. Dual luciferase assay indicated that CD274 was a direct target of miR-4429. Overexpression of miR-4429 in 786-O, Caki-2 cells significantly inhibited CD274 expression. KEGG results indicated that the potential target function of miR-4429 was associated with the PI3K/AKT signaling pathway, and protein blotting verified the results. In summary, this data shows that miR-4429 targets CD274 and inhibits ccRCC proliferation, migration, and invasion by regulating PI3K/AKT signaling, thus potentially providing a promising therapeutic target and prognostic biomarker for renal cell carcinoma patients. Graphical Abstract

30 December 2019 in Andrology
Verified
Journal Article
Open access
PDF file
SYSonglei Yan
Songlei Yan
TLTao Li
Tao Li
HSHua Shi
Hua Shi
A fascinating research on management of erectile dysfunction (ED) after radical prostatectomy (RP) was reported. They described the efficacy of end‐to‐side somatic‐to‐autonomic nerve grafting on restoring erectile function (EF). Finally, this technique improved EF for 71% (12/17) ED patients after RP, while 29% were failed. Actually, Souza Trindade et al. has previous investigated this technique to improve EF after RP, however, 40% was failed [1]. Meanwhile, compared with the control rats, end‐to‐side neurorrhaphy also presented significantly lower EF after donor somatic nerve impairment [2].